Cargando…
4-hydroxytamoxifen does not deteriorate cardiac function in cardiomyocyte-specific MerCreMer transgenic mice
Conditional, cell-type-specific transgenic mouse lines are of high value in cardiovascular research. A standard tool for cardiomyocyte-restricted DNA editing is the αMHC-MerCreMer/loxP system. However, there is an ongoing debate on the occurrence of cardiac side effects caused by unspecific Cre acti...
Autores principales: | Heinen, Andre, Gödecke, Stefanie, Flögel, Ulrich, Miklos, Dominika, Bottermann, Katharina, Spychala, André, Gödecke, Axel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864833/ https://www.ncbi.nlm.nih.gov/pubmed/33544211 http://dx.doi.org/10.1007/s00395-020-00841-9 |
Ejemplares similares
-
Generation of NSE-MerCreMer Transgenic Mice with Tamoxifen Inducible Cre Activity in Neurons
por: Kam, Mandy Ka Man, et al.
Publicado: (2012) -
Effects of tamoxifen inducible MerCreMer on gene expression in cardiac myocytes in mice
por: Rouhi, Leila, et al.
Publicado: (2022) -
A Murine Myh6(MerCreMer) Knock-In Allele Specifically Mediates Temporal Genetic Deletion in Cardiomyocytes after Tamoxifen Induction
por: Yan, Jianyun, et al.
Publicado: (2015) -
Moderate and high amounts of tamoxifen in αMHC-MerCreMer mice induce a DNA damage response, leading to heart failure and death
por: Bersell, Kevin, et al.
Publicado: (2013) -
Insulin-Like Growth Factor 1 Attenuates the Pro-Inflammatory Phenotype of Neutrophils in Myocardial Infarction
por: Nederlof, Rianne, et al.
Publicado: (2022)